Complete Loss of EPCAM Immunoexpression Identifies

EPCAM colon polyps colorectal cancer immunohistochemistry lynch syndrome

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
29 Sep 2020
Historique:
received: 25 07 2020
revised: 23 09 2020
accepted: 26 09 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 3 10 2020
Statut: epublish

Résumé

The use of epithelial cell adhesion molecule (EPCAM) immunohistochemistry (IHC) is not included in the colorectal cancer (CRC) screening algorithm to detect Lynch syndrome (LS) patients. The aim of the present study was to demonstrate that EPCAM IHC is a useful tool to guide the LS germ-line analysis when a loss of MSH2 expression was present. We retrospectively studied MSH2 and EPCAM IHC in a large series of 190 lesions composed of malignant neoplasms (102), precursor lesions of gastrointestinal (71) and extra-gastrointestinal origin (9), and benign neoplasms (8) from different organs of 71 patients suspicious of being LS due to

Identifiants

pubmed: 33003511
pii: cancers12102803
doi: 10.3390/cancers12102803
pmc: PMC7599495
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI17/01304; PI16/00766; PI19/01867
Organisme : Agencia de Gestió d'Ajuts Universitaris i de Recerca
ID : 2017SGR653; 2017 SGR 1035
Organisme : Research Project Award, Hospital Universitari General de Catalunya
ID : 2018

Références

Food Chem Toxicol. 2018 Aug;118:198-203
pubmed: 29751076
J Clin Oncol. 2011 Jan 10;29(2):223-7
pubmed: 21115857
Hum Pathol. 2014 Jul;45(7):1388-96
pubmed: 24768606
J Clin Pathol. 2011 May;64(5):415-20
pubmed: 21415054
Cancer Prev Res (Phila). 2011 Oct;4(10):1556-62
pubmed: 21791569
Histopathology. 2016 Aug;69(2):322-8
pubmed: 26826556
Clin Epigenetics. 2015 Jul 22;7:71
pubmed: 26203307
Fam Cancer. 2015 Mar;14(1):61-8
pubmed: 25173403
J Mol Diagn. 2009 May;11(3):238-47
pubmed: 19324997
Cancer Prev Res (Phila). 2012 Apr;5(4):574-82
pubmed: 22262812
Gastroenterol Hepatol. 2016 Oct;39(8):500-7
pubmed: 26790715
Genet Med. 2019 Oct;21(10):2167-2180
pubmed: 31086306
Clin Genet. 2012 Jul;82(1):97-9
pubmed: 22243433
Histopathology. 2017 Mar;70(4):664-669
pubmed: 27896849
QJM. 2016 Mar;109(3):151-8
pubmed: 26224055
Lancet Oncol. 2011 Jan;12(1):49-55
pubmed: 21145788
Nat Rev Cancer. 2015 Mar;15(3):181-94
pubmed: 25673086
Hum Pathol. 2013 Mar;44(3):412-6
pubmed: 23026194
Hum Mutat. 2009 Feb;30(2):197-203
pubmed: 19177550
J Pathol. 2012 Apr;226(5):764-74
pubmed: 22081473
Mod Pathol. 2012 May;25(5):722-30
pubmed: 22322191
Genet Med. 2016 Aug;18(8):823-32
pubmed: 26681312
Gastroenterology. 2008 Aug;135(2):429-37
pubmed: 18572020
Oncotarget. 2016 Mar 22;7(12):13372-87
pubmed: 26528695
Eur J Hum Genet. 2020 Mar;28(3):277-286
pubmed: 31695176
Crit Rev Oncol Hematol. 2017 Aug;116:38-57
pubmed: 28693799
Hum Mutat. 2019 Feb;40(2):142-161
pubmed: 30461124
Mod Pathol. 2018 Oct;31(10):1608-1618
pubmed: 29884888
J Mol Diagn. 2011 Jan;13(1):93-9
pubmed: 21227399
Genes Chromosomes Cancer. 2013 Sep;52(9):845-54
pubmed: 23801599
Mod Pathol. 2005 Aug;18(8):1095-101
pubmed: 15731775
Gastroenterology. 2014 Aug;147(2):502-26
pubmed: 25043945
Mod Pathol. 2017 Aug;30(8):1144-1151
pubmed: 28548127
J Mol Diagn. 2005 May;7(2):160-70
pubmed: 15858139
Eur J Cancer. 2018 Nov;104:91-103
pubmed: 30342310
Mod Pathol. 2012 Jun;25(6):911-6
pubmed: 22388758
Cancer. 2019 Sep 15;125(18):3172-3183
pubmed: 31150123
Nat Genet. 2014 Feb;46(2):107-115
pubmed: 24362816
Oncotarget. 2020 Apr 07;11(14):1244-1256
pubmed: 32292574
Lancet Oncol. 2011 Jan;12(1):5-6
pubmed: 21195320
Histopathology. 2009 Oct;55(4):414-22
pubmed: 19817892
Gastroenterology. 2004 Jan;126(1):42-8
pubmed: 14699485
Genes Chromosomes Cancer. 2009 Aug;48(8):737-44
pubmed: 19455606
Gastroenterology. 2010 Jun;138(6):2044-58
pubmed: 20420945
Nat Rev Dis Primers. 2016 Dec 01;2:16086
pubmed: 27905473
Gut. 2000 Jul;47(1):37-42
pubmed: 10861262
Front Biosci. 2008 Jan 01;13:3096-100
pubmed: 17981779
Cancer Res. 2010 Apr 15;70(8):3098-108
pubmed: 20388775
Nat Genet. 2009 Jan;41(1):112-7
pubmed: 19098912

Auteurs

Míriam Cuatrecasas (M)

Department of Pathology, Center of Biomedical Diagnosis (CDB), Hospital Clínic, 08036 Barcelona, Spain.
Universitat de Barcelona (UB), 08007 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 08036 Barcelona, Spain.

Iñigo Gorostiaga (I)

Department of Pathology, Hospital Universitario de Araba, 01009 Vitoria-Gasteiz, Spain.

Cristina Riera (C)

Gastroenterology Department, Hospital Universitari General de Catalunya-Grupo Quirónsalud, Sant Cugat del Valles, 08195 Barcelona, Spain.

Esteban Saperas (E)

Gastroenterology Department, Hospital Universitari General de Catalunya-Grupo Quirónsalud, Sant Cugat del Valles, 08195 Barcelona, Spain.
Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, 08017 Barcelona, Spain.

Gemma Llort (G)

Oncology Department, Parc Taulí Hospital Universitari, Sabadell, 08208 Barcelona, Spain.
Oncology Department, Consorci Sanitari de Terrassa, Terrassa, 08208 Barcelona, Spain.

Irmgard Costa (I)

Department of Pathology, Parc Taulí Hospital Universitari, Sabadell, 08208 Barcelona, Spain.

Xavier Matias-Guiu (X)

Universitat de Barcelona (UB), 08007 Barcelona, Spain.
Department of Pathology, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Department of Pathology, Hospital Universitari Arnau de Vilanova, 25198 Lleida, Spain.
Universitat de Lleida, IRBLLEIDA, 25003 Lleida, Catalonia, Spain.
Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.

Cristina Carrato (C)

Department of Pathology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.

Matilde Navarro (M)

Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Hospitalet de Llobregat, 08908 Barcelona, Spain.

Marta Pineda (M)

Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Hospitalet de Llobregat, 08908 Barcelona, Spain.

Núria Dueñas (N)

Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Hospitalet de Llobregat, 08908 Barcelona, Spain.

Joan Brunet (J)

Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Girona (IDIBGI), Universitat de Girona, 17190 Girona, Spain.

Vicente Marco (V)

Department of Pathology, Hospital Quirónsalud Barcelona, 08023 Barcelona, Spain.

Isabel Trias (I)

Department of Pathology, Hospital Platón, 08006 Barcelona, Spain.

José Ignacio Busteros (JI)

Department of Pathology, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Madrid, Spain.

Gemma Mateu (G)

Department of Pathology, University Hospital Josep Trueta, 17007 Girona, Spain.

Francesc Balaguer (F)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 08036 Barcelona, Spain.
Gastroenterology Department, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, 08036 Barcelona, Spain.

María-Teresa Fernández-Figueras (MT)

Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, 08017 Barcelona, Spain.
Department of Pathology, Hospital Universitari General de Catalunya-Grupo Quirónsalud, Sant Cugat del Vallès, 08190 Barcelona, Spain.

Manel Esteller (M)

Universitat de Barcelona (UB), 08007 Barcelona, Spain.
Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.

Eva Musulén (E)

Department of Pathology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Department of Pathology, Hospital Universitari General de Catalunya-Grupo Quirónsalud, Sant Cugat del Vallès, 08190 Barcelona, Spain.
Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.

Classifications MeSH